In fact, in a melanoma DC vaccine clinical trial with low-dose cytokines (IL-2 and IFN-gamma), Tregs were significantly increased by the fourth dose of the DC vaccine and were correlated with disease progression73. The gene discussed is IFNG; the disease is melanoma.